Exact Mass: 269.02532540000004
Exact Mass Matches: 269.02532540000004
Found 326 metabolites which its exact mass value is equals to given mass value 269.02532540000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-Acetyl-L-glutamyl 5-phosphate
N-Acetyl-L-glutamyl 5-phosphate is an intermediate in urea cycle and metabolism of amino groups. The enzyme N-acetyl-gamma-glutamyl-phosphate reductase [EC:1.2.1.38] catalyzes the conversion of this metabolite into N-acetyl-L-glutamate 5-semialdehyde. This reaction is irreversible and occurs in the mitochondria. (BiGG database) [HMDB] N-Acetyl-L-glutamyl 5-phosphate is an intermediate in urea cycle and metabolism of amino groups. The enzyme N-acetyl-gamma-glutamyl-phosphate reductase [EC:1.2.1.38] catalyzes the conversion of this metabolite into N-acetyl-L-glutamate 5-semialdehyde. This reaction is irreversible and occurs in the mitochondria. (BiGG database).
2-(p-Methoxyphenyl)-3-(m-chlorophenyl)acrylonitrile
(±)-Mephosfolan
(±)-Mephosfolan is an Agricultural insecticide with contact and stomach action, now supersede
Sulfamethoxazole N4-hydroxylamine
Sulfamethoxazole N4-hydroxylamine is a metabolite of Sulfamethoxazole. Sulfamethoxazole n4-hydroxylamine belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2. D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
5-Hydroxysulfamethoxazole
5-Hydroxysulfamethoxazole belongs to the family of Aminophenol Derivatives. 5-Hydroxysulfamethoxazole is a metabolite of Sulfamethoxazole. Sulfamethoxazole (abbreviated SMZ or SMX) is a sulfonamide bacteriostatic antibiotic.
2-Amino-6-chloro-9-(2,3-dideoxy-beta-D-glycero-pentofuranosyl)-9H-purine
Alinidine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Dansyl chloride
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003619 - Dansyl Compounds
3-(5-Acetamido-2-hydroxyphenyl)sulfanyl-2-oxopropanoic acid
C11H11NO5S (269.03579160000004)
Sulfamethoxazole N4-hydroxylamine
3,4-DIHYDRO-2,2-DIOXO-7-METHOXYCARBONYL-1-METHYLBENZO[2,1-C]THIAZIN-4-ONE
C11H11NO5S (269.03579160000004)
ETHYL 2-CYANO-3-[4-(TRIFLUOROMETHYL)PHENYL]ACRYLATE
Ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate
(2E,4E)-1-PHENYL-4-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)BUT-2-EN-1-ONE
5-Methoxy-9-oxo-9,10-dihydroacridine-4-carboxylic acid
Methyl 2-bromo-6-methyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylate
ethyl 6-bromoimidazo[1,2-a]pyrimidine-2-carboxylate
7-Chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid
9-OXO-9H-THIOXANTHENE-3-CARBONITRILE-10,10-DIOXIDE
C14H7NO3S (269.01466320000003)
(4-(4-Chlorophenoxy)phenyl)methanamine hydrochloride
4-[2-Chloro-5-(trifluoromethyl)phenyl]-3-thiosemicarbazide
C8H7ClF3N3S (269.00012879999997)
METHYL 3-(2-CHLORO-6-FLUOROPHENYL)-5-METHYLISOXAZOLE-4-CARBOXYLATE
Carbamicacid, (5-bromo-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Methyl 2-Amino-3-chloro-5-(trifluoromethoxy)benzoate
6-(2,3-difluorophenyl)pyridine-2-carboximidamide,hydrochloride
4-chloro-5,8-dimethylquinoline-2-carboximidamide,hydrochloride
ethyl 6-bromoimidazo[1,2-b]pyridazine-2-carboxylate
(Z)-2-(1H-Imidazole-1-yl)-2,4-dichloroacetophenone oxime
4-(2,4,6-trifluorobenzoyl)-1H-pyrrole-2-carboxylic acid
2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-6-((TRIMETHYLSILYL)ETHYNYL)FURO[3,2-B]PYRIDINE
C11H11NO5S (269.03579160000004)
{[4-(3-CHLOROPHENYL)-4H-1,2,4-TRIAZOL-3-YL]THIO}ACETIC ACID
3-Quinolinecarboxylic acid,1,4-dihydro-4-oxo-8-sulfo-
4-Thiazolidinecarboxylicacid, 2-(3,4-dimethoxyphenyl)-
1-[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]ethanone
3-BENZYL-5-(2-HYDROXYETHYL)-4-METHYLTHIAZOLIUM CHLORIDE
6-bromo-1,2,3,4-tetrahydro-quinoline-2-carboxylic acid methyl ester
(4-Chloro-3-(morpholine-4-carbonyl)phenyl)boronic acid
METHYL 2-AMINO-2-(4-(TRIFLUOROMETHYL)PHENYL)ACETATE HYDROCHLORIDE
5-Bromo-3-((trimethylsilyl)ethynyl)pyrazin-2-amine
(S)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOIC ACID HYDROCHLORIDE
5-(chloromethyl)-3-[(4-nitrophenoxy)methyl]-1,2,4-oxadiazole
(3-Chloro-5-(morpholine-4-carbonyl)phenyl)boronic acid
1-[3-(2,4-DICHLOROPHENYL)-5-METHYLISOXAZOL-4-YL]ETHAN-1-ONE
N-[4-(2-Amino-4-thiazolyl)phenyl]methanesulfonamide
4-(2,3-DICHLOROPHENYL)-1H-PYRROLE-3-CARBOXYLICACIDMETHYLESTER
Methyl 4-(3,4-dichlorophenyl)-1H-pyrrole-3-carboxylate
6-(CHLOROMETHYL)-N-(4-CHLOROPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE
METHYL 7-CHLORO-2-METHYL-3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-2-CARBOXYLATE
Propatyl nitrate
C6H11N3O9 (269.04952760000003)
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DA - Organic nitrates C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
Oncrasin-1
Oncrasin-1 is a highly effective anti-cancer inhibitor that can kill various K-Ras mutant human lung cancer cells at low concentrations.
1-[1-(2,3-DICHLOROPHENYL)-5-METHYL-1H-1,2,3-TRIAZOL-4-YL]ETHAN-1-ONE
4-Pyridinecarboxylicacid, 2-chloro-3-cyano-6-methyl-5-nitro-, ethyl ester
(2,4-Dioxo-1,2,3,4-tetrahydro-pyrimidin-5-ylamino)-fumaric acid dimethyl ester
Ethyl 6-bromopyrazolo[1,5-a]pyrimidine-2-carboxylate
Methanesulfonic acid, 1,1,1-trifluoro-, 4-[(1R)-1-aminoethyl]phenyl ester
3-[(4-chlorophenoxy)methyl]-4-ethyl-1H-1,2,4-triazole-5-thione
C11H12ClN3OS (269.03895719999997)
5-(((5-(TERT-BUTYL)OXAZOL-2-YL)METHYL)THIO)THIAZOL-2-AMINE
1-[3-(2,3-DICHLOROPHENYL)-5-METHYL-4-ISOXAZOLYL]-1-ETHANONE
5-Chloro-2-(morpholine-4-carbonyl)phenylboronic acid
Methyl 2-bromo-3-methyl-3H-imidazo[4,5-b]pyridine-6-carboxylate
(3S,4R)-4-(3-bromophenyl)pyrrolidine-3-carboxylic acid
(3S,4R)-4-(2-bromophenyl)pyrrolidine-3-carboxylic acid
(3S,4R)-4-(4-bromophenyl)pyrrolidine-3-carboxylic acid
6-AMINO-2-([(2,3-DIFLUOROPHENYL)METHYL]SULFANYL)-3,4-DIHYDROPYRIMIDIN-4-ONE
4-[(1,1-Dioxo-1lambda~6~,4-thiazinan-4-yl)-methyl]benzenecarboxylic acid
Sulfasomizole
C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent
1-(2-METHOXYETHYL)-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE
(R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOIC ACID HYDROCHLORIDE
2-BROMO-4-TERT-BUTYLPHENYLISOTHIOCYANATE
C11H12BrNS (268.98737719999997)
Methyl 2-Amino-2-(3,5-dichlorophenyl)acetate Hydrochloride
4-Quinolinecarboxylic acid, 2-(trifluoromethyl)-, ethyl ester
ethyl 2-(2,6-difluorophenyl)thiazole-4-carboxylate
4-(CHLOROMETHYL)-2-(3,4-DIMETHOXYPHENYL)-1,3-THIAZOLE HYDROCHLORIDE
Methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate
1-[1-(3,5-dichlorophenyl)-5-methyltriazol-4-yl]ethanone
Ethyl 2-(2,4-difluorophenyl)thiazole-4-carboxylate
(3-CHLORO-4-(MORPHOLINE-4-CARBONYL)PHENYL)BORONIC ACID
(S)-(+)-5-(Hydroxymethyl)-2-pyrrolidinone p-toluenesulfonate
2-pyridin-2-yl-4-(trifluoromethyl)pyrimidine-5-carboxylic acid
1-(5-bromo-4-methylpyridin-2-yl)-4-methylpiperazine
1-Piperidinecarboxylic acid, 4-iodo-, Methyl ester
3-(4-chlorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride
1-(benzo[d][1,3]dioxol-5-yl)-2-(6-Methylpyridin-2-yl)ethane-1,2-dione
ethyl 7-chloro-6-fluoro-4-hydroxyquinoline-3-carboxylate
ethyl 5-chloro-6-(chloromethyl)pyridine-3-carboxylate,hydrochloride
(6-[4-(TRIFLUOROMETHOXY)PHENYL]PYRIDIN-3-YL)METHANOL
3-(6-Hydroxybenzodioxol-5-yl)-1,3-dihydro-2H-indol-2-one
1-(5-CHLORO-METHOXYPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID
4-[4-Chloro-3-(trifluoromethyl)phenyl]-3-thiosemicarbazide
C8H7ClF3N3S (269.00012879999997)
1-(2,1,3-Benzothiadiazol-5-yl)-2-(6-Methyl-2-pyridinyl)ethanone
1-Methyl-5-[4-(trifluoromethyl)phenyl]pyrrole-2-carboxylic Acid
(R)-2-(2-Fluoro-5-(trifluoromethyl)phenyl)pyrrolidine hydrochloride
2,3-Dichloro-N-(2-fluorobenzyl)aniline
C13H10Cl2FN (269.01742920000004)
1-(4-Chloro-pyridin-2-yl)-piperazine dihydrochloride
C9H14Cl3N3 (269.02532540000004)
2,6-Dichloro-N-(2-fluorobenzyl)aniline
C13H10Cl2FN (269.01742920000004)
2,6-Dichloro-N-(3-fluorobenzyl)aniline
C13H10Cl2FN (269.01742920000004)
(4S)-2-(3,5-Dimethoxyphenyl)-1,3-thiazolidine-4-carboxylic acid
1-(2,4-DICHLORO-BENZYL)-3,5-DIMETHYL-1H-PYRAZOL-4-YLAMINE
Ethyl 6-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate
4-thiophen-2-yl-4,10-dihydro-[1,3,5]triazino[1,2-a]benzimidazol-2-amine
5-BROMO-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLICACIDMETHYLESTER
1-(3-CHLORO-4-METHOXYPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID
2-NITRO-ALPHA-[(2,2,2-TRIFLUOROETHOXY)METHYL]-IMIDAZOLE-1-ETHANOL
Manganese(II) chloride tetrahydrofuran complex (1:2)
Methyl 2-amino-2-(3,4-dichlorophenyl)acetate hydrochloride
ETHYL 5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBOXYLATE
3-(4-chlorophenyl)-4-(2-methoxyethyl)-1H-1,2,4-triazole-5-thione
C11H12ClN3OS (269.03895719999997)
1-(5-BROMO-PYRIDIN-2-YL)-PYRROLIDIN-3-YL]-DIMETHYLAMINE
(4-((1H-Tetrazol-5-yl)carbamoyl)phenyl)boronic acid hydrochloride
C8H9BClN5O3 (269.04869440000004)
(3-((1H-TETRAZOL-5-YL)CARBAMOYL)PHENYL)BORONIC ACID HYDROCHLORIDE
C8H9BClN5O3 (269.04869440000004)
Methyl 4-hydroxy-2-methyl-(2H)-1,2-benzothiazine-3-carboxylate-1,1-dioxide
C11H11NO5S (269.03579160000004)
2-THIOPHEN-2-YL-QUINOLINE-4-CARBOXYLICACIDHYDRAZIDE
3,3-BIS-METHYLSULFANYL-1-(4-NITRO-PHENYL)-PROPENONE
2-Chlorodideoxyadenosine
D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides
4-(4-methylphenyl)-5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol
2-(4-Methylanilino)-4-pyrido[3,2-e][1,3]thiazinone
(1E,4E)-1-(2,4-dichlorophenyl)-5-(dimethylamino)penta-1,4-dien-3-one
2-Methyl-3-(thiophene-2-carbonyl)-indolizine-1-carbaldehyde
2-(2-Chloro-3-pyridinyl)-1-prop-2-enylbenzimidazole
3-chloro-N-(2-methyl-3-oxo-1,2,4-thiadiazol-5-yl)benzamide
1-Phenyl-2-([1,2,4]triazolo[4,3-a]pyridin-3-ylthio)ethanone
2-Chloro-4-(pyridin-3-yl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile
6-methoxy-4-methylbenzo[g]quinoline-2,5,10(1H)-trione
A natural product found in Annona glabra.
Emodin(1-)
A phenolate anion that is the conjugate base of emodin, obtained by deprotonation of the phenolic hydroxy group at position 2; major species at pH 7.3 (according to Marvin v 6.2.0.).
Genistein(1-)
An organic anion that is the conjugate base of genistein, obtained by selective deprotonation of the 7-hydroxy group.
beta-(2,6-anhydro-3-deoxy-D-arabino-heptulopyranosid)onate 7-phosphate
C7H10O9P-3 (269.00624400000004)
alpha-(2,6-anhydro-3-deoxy-D-arabino-heptulopyranosid)onate 7-phosphate
C7H10O9P-3 (269.00624400000004)
Baicalein(1-)
A flavonoid oxoanion obtained by deprotonation of the hydroxy group at position 7 of baicalein. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
2-[(pyridin-2-ylsulfanyl)methyl]quinazolin-4(1H)-one
4-Oxo-4-thiophen-2-ylbutanoic acid [2-(ethylamino)-2-oxoethyl] ester
3-Methyl-2-thiophenecarboxylic acid [2-(4-morpholinyl)-2-oxoethyl] ester
2-Thiophenecarboxylic acid [2-oxo-2-(2-oxolanylmethylamino)ethyl] ester
[2-(6-bromo-1H-indol-3-yl)-2-hydroxyacetyl]azanium
C10H10BrN2O2+ (268.99255999999997)
(2R)-2-acetamido-3-[(R)-benzylsulfinyl]propanoic acid
4-Nitrophenoxyacetic acid trimethylsilyl ester
C11H15NO5Si (269.07194599999997)
Dansyl chloride
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003619 - Dansyl Compounds
sulfamethoxazole hydroxylamine
A sulfonamide compound having a 4-hydroxylaminophenyl group attached to the sulfur atom and a 1,2-oxazol-3-yl group attached to the nitrogen atom. D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
phosphatidylethanolamine 37:0
A phosphatidylethanolamine in which the two acyl groups contain a total of 37 carbons and no double bonds.
phosphatidylethanolamine 19:1
A 1,2-diacyl-sn-glycero-3-phosphoethanolaminein which the two phosphatidyl acyl groups contain a total of 19 carbons and 1 double bond.
pelargonidin(1-)
An organic anion obtained by selective deprotonation of the 3- and 5-hydroxy groups of pelargonidin; major species at pH 7.3.
nataloe-emodin(1-)
A phenolate anion that is the conjugate base of nataloe-emodin, obtained by deprotonation of the phenolic hydroxy group at position 2. Major species at pH 7.3.
baeocystin(1-)
An organophosphate oxoanion obtained by deprotonation of the phosphate and protonation of the amino group of baeocystin; major species at pH 7.3.
RETRA
RETRA is a mutant p53-dependent activator of p73 that suppresses mutant p53-bearing cancer cells. RETRA increases the expression level of p73, and a release of p73 from the blocking complex with mutant p53, which produces tumor-suppressor effects[1].
